Victrex (GB:VCT) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Victrex PLC reports a 4% increase in full-year volumes despite a 5% decline in group revenue, attributed to medical destocking and currency impacts. The company focuses on growth for FY 2025, with robust pricing and strategic advancements in key mega-programmes such as aerospace composites and e-mobility. Improved cash conversion and strong cost control are expected to support profitability and shareholder returns.
For further insights into GB:VCT stock, check out TipRanks’ Stock Analysis page.
